These final results, along with a former report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 help the strategy of concentrating on ACKR3 as a unique way to modulate the opioid system, which could open new therapeutic avenues for opioid-associated disorders. These results suggest that https://francisz061tjz6.blogproducer.com/profile